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Abstract
Introduction: Establishing an effective midline program involves more than simply learning an insertion technique for a
new product. Midline catheters provide a reliable vascular access option for those patients with difﬁcult venous access who
would otherwise require multiple venipunctures or the use of higher-risk central lines to maintain access. An effective
midline program establishes a protocol for device selection and includes standing orders to facilitate speed to placement.
Methods: Our retrospective descriptive review evaluated the successful integration of midline programs into existing
vascular access bedside insertion programs in 2 acute care hospitals. The investigator reviewed a convenience sample of
hospital patients. Participants in the study included vascular access team managers and team members from the sample sites.
Results: The results of this 2-hospital study demonstrate successful integration of a midline program into a bedside
insertion program with 0 midline-related infections since initiation. Documentation of overall central line-associated
bloodstream infection rates for hospital 1 changed from 1.7/1000 catheter-days to 0.2/1000 catheter-days, reﬂecting a
78% reduction in infections and a projected cost avoidance of $531,570 annually. Both hospitals demonstrated reduced
rates of infection following implementation of a midline program.
Conclusions: Midlines have a history of lower risk for both infection and thrombosis compared with central venous
devices. Although more research is needed on the more recently developed midline catheters, available evidence suggests
that midlines provide a safe and reliable form of vascular access, reducing costs and the risk of infection associated with
central venous catheters, especially those placed solely for patients with difﬁcult venous access.
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2015Introduction
electing the best vascular access device for a patient in-
volves having a clear understanding of what options areS available for either low-risk peripheral access or central
access when infusates require central administration. With
the vast majority of acute-care patients requiring intravenous
medication and venous access, the need continues for
expanded options for reliable extended access devices that
can be inserted by nurses. Short peripheral catheters may not
always serve the needs of patients, especially those with
difﬁcult-to-access veins. The slightly longer midline catheter
works well with intermediate needs of a few days to a month
or more. This continued need for reliable, extended vascularj Vol 20 No 3 j JAVA j 179
access has caused a resurgence of interest in midlines for both
acute care and home care applications.
Peripherally inserted central catheters (PICCs) have continually
gained in popularity in the United States during the past 25 years.
Now there are approximately 2.5 million inserted per year, the
majority of which are placed by nurses.1 There are currently con-
cerns with PICCs and all central venous access devices (CVADs)
regarding the development of central line-associated bloodstream
infections (CLABSIs) and the reimbursement penalties associated
with these infections. Midlines provide a viable alternative to cen-
tral lines when the primary need is for reliable access of 5 days or
more and central placement is not indicated. The use of midlines
is consistent with the Centers for Disease Control and Prevention
(CDC) recommendations for safe strategies to reduce CLABSIs.2
Midlines have a history of lower risk for both infection and
thrombosis than CVADs and should be considered as a beneﬁcial
option for patients.3-8 Evaluating patients on an individual basis
for the most appropriate device (eg, peripheral short catheter,
ultrasound-guided longer catheter, midline, PICC, internal jugu-
lar, subclavian, or other long-term device) follows the goal of
vessel health and preservation.9,10 Enabling specialty teams to
choose devices and insert catheters based on patient need in-
creases efﬁciency in treatment delivery, hospital through-put,
and patient satisfaction.11-20 Creation of a policy and referral pro-
cess that includes midlines should be a part of an overall hospital
strategy to reduce infections while effectively delivering treat-
ment plans.3-5,7,21-25 The aim of our study was to provide a
descriptive review of 2 acute care hospital midline catheter
programs.
Methods
This was a 2-site, retrospective descriptive review to eval-
uate midline programs successfully integrated into existing
vascular access programs. Inclusion criteria were for a 2-
cohort sample of acute care hospitals with operating midline
programs consisting of bedside insertions, policies, and out-
comes of >2 years. Excluded were hospitals without func-
tional midline protocols and hospitals in excess of 2. This
project was designed as a case study; aggregated facility public
outcomes were based on data collected from prior years of hos-
pital use and surveillance for CLABSI using National Health
Safety Network deﬁnitions. No patient medical information
or medical records were reviewed in conjunction with this
case study. Management, institutional review board, and ethics
chairs approved this case study under waiver without full sub-
mission in accordance with federal policy and found it exempt
because it used public or privately held records or interview
procedures without access to patient health information.
Amidline catheter, as deﬁned by the InfusionNurses Society, is a
venous catheter access device measuring 3-8 in (6-20 cm) with the
distal tip in the basilic, brachial, or cephalic veins at or below the axil-
lary fold, distal to the shoulder.26 Difﬁcult intravenous access
(DIVA)was deﬁned byKeyes in 199927 as 2 unsuccessful attempts,
by Costantino in 2005 as the inability to obtain intravenous access
after at least 3 attempts in a group of patientswith knowndifﬁcult ac-
cess,28 and by Weiner in 201229 as those patients with 2 or more
failed attempts or with known history of difﬁcult intravenous180 j JAVA j Vol 20 No 3 j 20placement. A literature review of midline use from 1985-2015 was
performed with results integrated into the study discussion.
Study Procedures
The investigator reviewed a convenience sample of hospi-
tals to determine their eligibility for inclusion into the study
based on having an existing midline program. The 2 hospitals
meeting the inclusion criteria submitted their policies and out-
lines of their programs, subsequently receiving approval for
the study. Participants in the study included vascular access
team managers and team members from the sample sites.
The results of observations and interviews were used to
describe the recommended processes to develop an effective
midline program. Processes for acquiring information involved
a series of interviews with team managers and team members
with a focus on program development, motivation for develop-
ment, structure of the program, device use, challenges and
solutions, midline indications, infection outcomes, and use of
staff education for integration of the program.
Participants and Setting
Hospital 1
The ﬁrst hospital, an urban Midwestern 400-bed Magnet-
recognized (American Nurses Credentialing Center’s (ANCC)
Magnet Recognition Program) teaching hospital designated
as a level-1 trauma center, had been working to reduce CLAB-
SIs since 2006. Infection control professionals identiﬁed a
plateau in the reduction of bloodstream infections from 2009-
2012 and were motivated to make changes. The CLABSI
committee, dedicated to reducing CLABSIs, re-emphasized ed-
ucation of the central line bundle (previously implemented) for
all CVAD insertions.30 Secondary solutions included an evalu-
ation of patient indications before each CVAD placement with
an intended goal of reducing the use of central lines, especially
peripherally inserted central catheters (PICCs), and implemen-
tation of ultrasound guidance for the placement of peripheral
and midline catheters for those patients whose main indication
was difﬁcult access, blood draws, computed tomography for
those patients requiring only a few days of therapy, and for pa-
tients whose medication did not require a CVAD. In 2010, a
proposal to create a vascular access team was submitted and
accepted for implementation. Originally formed under collabo-
rative practice with the interventional radiology department
where PICCs were placed by physicians, the nursing team
was organized to begin PICC placement at the bedsides.
The hospital originally approved a local midline policy spe-
ciﬁc to the diagnostic imaging department. The protocol,
which included evaluation of patients, device selection, and
insertion of midline catheters, was performed by the vascular
access team without requiring a physician’s order. As the pro-
gram expanded, the protocol was eventually submitted to the
medical director, risk management, and the entire system for
committee review and hospital-wide approval.
The midline program at this hospital was initiated with the
release of a new, accelerated Seldinger technique (AST)
midline device (Powerglide; Bard Access, Salt Lake City,
UT). The AST midline device was chosen due to an integrated15
Figure 1. Hospital 1
midline program
growth. PICC ¼ Periph-
erally inserted central
catheter.design that promoted speed and safety in the form of reducing
risk of contamination, air and wire embolization. Additional
midline products were used intermittently (Bard Poly Midline
Catheter, Per-Q-Cath Plus Midline Catheter, and Groshong
Midline Catheter, all from Bard Access), employing the
more traditional modiﬁed Seldinger technique (MST) insertion
method. The program was later modiﬁed transitioning to
another AST midline device (POWERWAND; Access Scienti-
ﬁc, San Diego, CA) in an attempt to resolve problems encoun-
tered with other devices. Following minor individual
adjustments, insertion success increased signiﬁcantly. For
example, 1 clinician found success with insertion of the needle,
then inversion of the bevel using ultrasound to guide the entire
needle/wire and catheter more deeply into the vessel,
anchoring the device in the vein. This “invert and insert” pro-
cess to shield the cutting point of the needle from damaging the
back wall of the vein increased success and ease of insertion.
In this hospital, the protocol for midline insertion was estab-
lished for patients with DIVA when requested from the bedside
nurse; or when identiﬁed through vascular access consult, evalu-
ation, and selection by the team. Consistent with other peripheral
devices, no physician’s order was required for placement of a
midline device. The daily patient assessment for central and
midline catheters was expanded to include assessment for signs
and symptoms of insertion site infection, evaluation of mainte-
nance compliance, and daily assessment for continued need of
the CVAD. Identiﬁcation of noncompliance resulted in opportu-
nities for teachablemomentswithbedside clinical staff. Education
of bedside staff was an important component in the integration of
midlines. The additional tier of surveillance (ie, in addition to reg-
ular bedside registered nurse and medical team assessment) to
assess for continued need of the CVAD offered opportunities
for early intervention and removal of the CVAD.
Hospital 2
The second study hospital is a 215-bed not-for-proﬁt hospital
located near Atlanta, GA. The motivation for development of a
midline program came after nursing representatives attended a2015conferencewhere a clinician presented a hospitalmidline study.31
The hospital, already questioning the need for so many PICCs,
agreed that midlines were an option that could offer additional
vascular access choices that may result in reduced CLABSIs
and provide added patient safety. A veteran team, based out of
the hospital’s cardiac catheterization lab, was placing 60-80
PICCs per month with 99% success rate using ultrasound-
guided placement and tip positioning (without navigation). The
midline program began in 2011 with 80-100 midline insertions
permonthusing theAST(POWERWAND).Despite a signiﬁcant
learning curve and variable levels of insertion success, the team
committed to this new device that consistently demonstrated su-
perior performance in patients. Consistent instruction by the com-
pany’s clinical representatives and a hospital clinician resulted in
a steady increase in successful insertions. The goals for device se-
lection focused on midlines for patients with DIVA along with
avoidance of unnecessary CVADs. The goal was to remove
PICCs and other CVADs early and replace them with a midline
or peripheral intravenous catheter before the patient was trans-
ferred to a routine medical/surgical ﬂoor. The team achieved
high levels ofﬂow (130-160ml/min)with the 4 and5Fr catheters.
Results
During the 12-monthperiod fromAugust 2011 toAugust 2012,
with the initiation of the Hospital 1 PICC and midline program, a
total of 589 insertions were performed by the team averaging a
99.4% success rate. Total PICC insertions for the ﬁrst 12 months
were 456 (see Figure 1 for breakdown of 4 years of insertions).
From 2012, when the team was up to full capacity, to 2014 the
PICC insertions declined from an average of 38 orders and inser-
tions per month to 16 per month, a 58% reduction in the average
number ofPICC insertions performed annually. The increased use
of midline catheters and subsequent reduction of PICCs was
consistent with the goal of CVAD placement only in evidence-
based indications. Figure 2 depicts the decline of CVAD use
from 0.48/100 device-days to 0.23/100 device-days. Orders
received for placement of PICCs for access or blood draws alone
were transitioned to midline placement. Midlines reﬂected aj Vol 20 No 3 j JAVA j 181
Figure 2. Central line use ratio (device-days/patient-days). ICU ¼ Intensive care unit; M/S ¼ Medical/
Surgical; SD ¼ Standard Device; CL ¼ Central Line.
steady rise from 2011-2013. Midline use increased from 2012-
2013 by 44% and in 2013-2014 decreased slightly by 22% as
shown in Figure 1.
In Hospital 2, midline insertions, which averaged 10-20 per
month (200 per year), for 2011-2012 doubled in 2012-2013 to
20-40 per month (400 per year), and in 2013-2014 averaged 80
permonth (960 per year). In both hospitals, peripheral catheter pol-
icy changed to allow catheters to be placed with ultrasound guid-
ance and under special conditions to dwell longer than 96 hours.
Midline requests with both facilities focused on patients
with DIVA with limited veins and the need to replace CVADs
with a lower-risk device. Peripheral catheters and midlines
were treated as nursing (not physician) options for patient ac-
cess. An increase in requests for midline placement from the
nephrology department was an unexpected result for Hospital
1 in an effort to save subclavian veins for future use.
In both hospitals, an increase in education for bedside
nurses, with an emphasis placed on vessel health and preserva-
tion, resulted in greater compliance in avoiding antecubital
veins for peripheral insertions and placement of the most
appropriate device early in hospitalization. Results of
enhanced vascular access education and mentoring becameFigure 3. Advocate Illinois Masonic Medical Cente
trend.
182 j JAVA j Vol 20 No 3 j 20apparent in Hospital 2 because emergency room personnel
began changing from an insertion practice of 100% device
placement in the antecubital fossa to avoidance of the antecu-
bital fossa for those patient slated for hospital admission.
No midline infections were reported for midlines since the
inception of this program for either of these hospitals. Documen-
tation of overall CLABSI rates fell from 1.7-0.2 from 2011 to
2014, reﬂecting a 78% reduction and a projected cost savings
of $531,570 annually for Hospital 1 (Figure 3). Hospital 2 re-
ported a 2014 facility-wide 0 CLABSI rate and 0 midline infec-
tion rate, attributing this success to the work of the team and their
use of midlines, early removal of CVADs, replacement of
CVADswith midlines, and an improvement in blood culture col-
lections. As a byproduct of better management of vascular access
and early insertion of the best device, steady improvement was
seen in both facilities in patient and nursing satisfaction. It was
noted that patients and nurses alike expressed their appreciation
for this additional venous access option.
Because the nurses on the team managing midline and PICC
insertions were originally emergency room and cardiac catheter
lab/interventional radiology nurses, a thought-process transition
was required from short-term/immediate procedure-orientedr central Line-associated bloodstream infection
15
solutions to longer-term analysis with assessment, device selec-
tion, and a focus on improving device-related patient outcomes.
Attendance at Association forVascular Access national and local
network meetings provided insights that contributed to overall
understanding and the development of better selection processes
for PICCs and midlines. Even when access was challenging, the
team made sure each patient had the safest feasible form of ac-
cess. The team committed to becoming more knowledgeable
and certiﬁed in vascular access and, to date, all but the most
recently hired clinician have achieved this designation (that clini-
cian is scheduled to take the examination).
As the team transitioned to being a vascular access specialty
team, respect grew among physicians for the efﬁciency of the
midline program and the quality of team services provided to pa-
tients. Critical care intensivists proactively began ordering the
high-ﬂow midline for replacement of PICCs and other CVADs
as patient conditions improved. The protocol and standing orders
established for this midline program did not require a physician’s
order; this facilitated bedsidenurses in gaining fast assistance from
the vascular access teamwhen patient access became challenging.
Regular education andmentoring offered by the teammembers
regarding vascular access selection and safe practices was an
essential ingredient to promoting understanding by the bedside
nurses andorderingphysicians.One component of educationprac-
ticed by this team was good mentoring of bedside nurses. Team
members found the majority of nurses wanted to listen and learn
about device care, dressings, aseptic access principles, and
CLABSI reduction practices. Working 1-on-1 with the nursing
staff, team members provided daily education through individual
mentoring, procedure demonstration, and by offering a leadership
example. Using this approach, nurses in the emergency room
learned ultrasound-guided peripheral catheter insertions. Four to
6 hours of consistent education was also provided to residents
and new orientees on the topic of vascular access safe practices.
Successful insertion of midlines became the norm as this
team applied a 2-person assisted midline placement for every
patient, similar to recommended PICC practice. Greater success
was achieved when performing insertions with an “invert and
insert” technique, where the needle bevel is rotated once inside
the vessel, reducing vein wall contact. A focus on inserting
midlines in the cephalic vein using a lower angle created the
best results. This team recognized that although no signiﬁcant
evidence existed to support the 2-person insertion technique,
the central line insertion bundle requires an observer to com-
plete the checklist and assist as needed. According to the Amer-
ican Society of Anesthesiologists guidelines, “The consultants
and ASA members agree that a trained assistant should be
used during the placement of a central venous catheter.”32
This insertion team experienced increased success and efﬁ-
ciency with 2 team members working together to complete in-
sertions and manage patients. The nurses made the ﬁfth vital
sign a priority, assessing for pain and providing ample anes-
thetic agents during insertion. The hospital noted a steady rise
in patient satisfaction with vascular access insertion and care;
this became a source of pride for the vascular access team.
When not inserting devices, team members performed consis-
tent rounding on all devices each day, assessing device function,2015dressings, and looking for opportunities to teach. With greater
success, orders for placement continued to grow and new team
members were needed. The team searched for new hires who
were assertive, willing to work, had good skills, and displayed
a positive attitude. With the team now up to 4 members working
10-hour staggered schedules Monday through Friday, the hospi-
tal receives coverage for 137 midline or PICC insertions per
month and 40 additional procedures such as dressing changes
per week. Bedside nurses are empowered to request midlines
for difﬁcult-access veins under the accepted protocol. To create
a cohesive team, this group and hospital leadership committed to
a transformational leadership approach that focuses on transpar-
ency, honesty, and a willingness to consider what is best for
everyone, including hospital and patient.
When considering differences betweenhospitals, few variations
were noted. Hospital 1 represented a more centralized team struc-
ture with the management and team leadership collection of out-
comes. The team at Hospital 2 shared many responsibilities with
a more transitional leadership style and a more relaxed approach
to statistical analysis. Despite the difference in leadership styles,
the implementation of a midline program within a functional
nursing-based bedside PICC program provided similar results.
Discussion
The results of this study provide a limited view of an effective
midline program, including insertion, establishing indications
for midlines and CVADs, and reducing CLABSI. There is a
growing need to reduce unnecessary central lines and focus on
evidence-based indications for the insertion of PICCs and other
CVADs. Finding other evidence-based alternatives to CVADs,
especially those placed for access only, or worse, with no clear
indication, provides much of the motivation behind the re-
emergence of midline catheters. Chopra et al33 and others have
published ﬁndings pointing to an increased risk of infection
and thrombosis associated with central venous catheters and spe-
ciﬁcally PICCs, highlighting the need for selection of these de-
vices only when medically indicated by the nature of infusates,
number of necessary access lumens, and the need for rapid large
volume infusion. Evidence points to midline catheters as the
safest option for vascular access treatment lasting 48 hours or
more when no clear indication exists for central venous catheter
insertion.3,6,31,34-37 Although all midline catheter devices are not
the same, reported complication rates for most midlines are
low.38 As stated by Maki39 in his review of midline catheters,
“CVADs are 20-300 times more expensive and are associated
with as much as a 20-fold higher rate of CLABSI” than periph-
eral catheters. With the average peripheral intravenous catheter
lasting only 44 hours or 1.9 days, patients requiring continued
treatment beneﬁt from a peripherally placed midline device
that can remain in place for the duration of treatment.37,40-44 Ac-
cording to the CDC, “Midline catheters appear to be associated
with lower rates of phlebitis than are short peripheral catheters
and lower rates of infection than CVADs.”2 Bacterial concentra-
tion on the arm is the lowest on the body, approximately 10 CFU/
cm2, making peripheral access a preferred insertion location
from the standpoint of infection.45,46 Infection rates associated
with midline catheters appear to make this device one of thej Vol 20 No 3 j JAVA j 183
safest in terms of infection with a range of 0-0.8/1000 catheter-
days with a mean of 0.2/1000 catheter-days in comparison to
central venous catheter infections 2.1/1000 catheter-days and
short peripheral catheters with projected infection rates of 0.5/
1000 catheter-days.2-4,6,7,38,45,47,48
Hospitals are moving to reduce central catheter-days in an
effort to reduce infections. Midline catheters may be considered
a good choice for certain patients requiring reliable venous ac-
cess and may also reduce the total number of central catheter-
days.49 Longer dwell times of CVADs are associated with an
increased risk of bloodstream infection.2,50 Central venous cath-
eters are commonly inserted during patient stays in intensive
care units and later left in place simply as a means of vascular
access, despite reduced need for central access. Millstone and
associates50 point to the need for routine replacement of central
catheters with peripheral access devices when central devices
are no longer needed. Midlines may serve this purpose,
providing an option for reliable, high-ﬂow access.
Midline catheters ﬁll a gap for patients requiring treatment
longer than 48 hours and consistently demonstrate safety
through lower thrombosis rates (<2.0%), phlebitis rates
(<11%), and longer dwell times (7.69-16.4 days) with comple-
tion of therapy 79%-89% of the time in comparison with both
peripheral and central venous catheters.4,6,7,23-25,31,38,47,51,52
According to Maki,39 one of the few randomized controlled tri-
als with short peripheral catheters, 27%-70% of peripheral
catheters become phlebitic; Strumpfer53 reports 50% of periph-
eral catheters become phlebitic within 72 hours and Anderson
demonstrated that a typical patient with pneumonia will have
at least 3 cannulations over a 5.6-day stay, representing the
economic break-even point for peripheral vs midline catheters.
Indications leading to the selection of a midline device:
1. Patients with DIVA,
2. Requirement for intravenous medications more than a
few days (ie, 4-5 days),
3. Computed tomography short-term needs,
4. Frequent blood draws with poor access,
5. Renal failure and pre-renal patients, and
6. CVAD no longer indicated with continuing vascular ac-
cess needs.
Patients with the following conditions are candidates for
midline catheters:
d Cellulitis
d Diabetes
d Pneumonia
d Congestive heart failure
d Abscess
d Bronchitis/asthma
d Pyelonephritis
d Osteomyelitis
d Chronic renal failure (with approval of nephrology)
d Major surgery
d Burns
d Obesity
d Malnutrition
d Dehydration
d Stroke/transient ischemic attack184 j JAVA j Vol 20 No 3 j 20d Contractures
d Multiple tattoos
d Poor vasculature
d Advanced age
d Chronic conditions
Treatment indications include:
d Continuous infusions, hydrating;
d Isotonic, lower osmolarity infusion (<600 mOsm);
d Antibiotic agents appropriate for peripheral infusion;
d Heparin, steroid, antacids, sedation, and analgesia/pain
medication infusions;
d Treatments requiring extended dwell without need of
central venous access; and
d Therapies that extend longer than 6 days or require reli-
able access.
Contraindication for midline catheter insertion include:
d Mastectomy or circulatory impairment in peripheral
circulation,
d Peripheral neuropathy,
d Venous thrombosis affecting peripheral circulation,
d Lymph node dissection or limitations to speciﬁc arm due
to surgery,
d Fistula (nephrology approval for patients experiencing
renal failure), and
d Skin conditions affecting the insertion area.
Midline program implementation can be challenging, as re-
ﬂected in the description of these 2 hospitals. Newer midline
designs have an integrated needle, wire, and catheter and use
an insertion process known as AST that requires a learning
curve to achieve greatest success. AST incorporates a change
in technique that may initially be challenging to some clini-
cians, just as ultrasound and MST often are to beginners. How-
ever, as with any skill, improvement comes with practice and
may include small adjustments such as those described in the
Hospital 1 and 2 details.
Complications associated with midline catheters were reported
in research byCaparas andHu,34 including leakage, dislodgment,
and inﬁltration; no infections were reported. Thrombosis and
phlebitis rates were 0 for the midline group. No vascular access
device is devoid of complications, but as the Caparas study
described, a midline program with team management resulted in
complications equal to that of PICCswith no statistical difference.
The rate of complications was 19.9% (leakage [n¼ 1], dislodge-
ment [n¼ 2], and inﬁltrations [n¼ 3]) with midlines and 17.9%
(bloodstream infection [n ¼ 1] and dislodgement [n ¼ 4]) with
PICCs. Issues of vessel health and preservation direct clinicians
to weigh midline vs CVAD risk-to-beneﬁt ratios, comparing the
potential complications with the beneﬁts of reliable access.
The economic incentive of “value-based purchasing”
coupled with patient satisfaction act as a driving force for hos-
pitals to consider processes and devices that are reliable and
safe, thus increasing quality. Issues related to CLABSIs and
the lack of reimbursement for prolonged hospitalization and
treatment undergird the need to choose intravenous devices
wisely. Devices such as midline catheters and the increased
use of ultrasound to insert peripheral intravenous cathers
both provide options to remove CVADs when they are no15
longer necessary, reducing the risk of CLABSI.54 Additional
economic gains associated with the use of midline catheters
include the elimination of costs associated with tip conﬁrma-
tion, which is not needed for midlines; the elimination of
thrombolytic agents for the treatment of occlusions; lower
insertion device costs; and the potential for reduced length
of stay.4,55,56 Caparas and Hu34 reported a cost savings of
$90 with each midline insertion compared with dual-lumen
PICCs.
In a recent review by Gorski et al,57 using pH levels as a sole
indicator for central venous catheter placement was refuted. The
conclusions stated medications such as vancomycin could be
safely administered through the deeper veins of the upper arm
using a midline; this result was supported by Caparas and
Hu.34 Dilution and consideration for a vancomycin concentra-
tion 5 mg/mL or less were discussed and references detailed
in the review by Gorski et al.57 In light of these ﬁndings, and
with a lack of evidence to the contrary, the decision to place
a CVAD based solely on the pH of the intended therapy, van-
comycin in particular, is not supported by the evidence.36 Cli-
nicians, physicians, pharmacists, and administration have long
debated the issue of administering vancomycin via peripheral
access. As represented in the review by Gorski et al,57 pH is
a factor primarily for parenteral nutrition and not antibiotic
agent infusions. This paradigm shift from concerns over pH
<5 or >9 requiring central venous access reﬂects a notable
change in practice and points to the need for careful consid-
eration of the characteristics of each medication, the potential
for irritation, optimal concentration, and the ability to safely
administer the medication through a peripheral or midline
catheter. More evidence exists speciﬁc to phlebitis, inﬁltra-
tion, and other complications, anecdotally reported as associ-
ated with vancomycin, but those outcomes may more likely
be associated with factors such as microparticles in solution
(as suggested by Maki39), individual patient risk factors such
as infection, inﬂammatory disease, cancer, and cardiovascu-
lar disease or hypercoagulable states.41,58 Despite the
reduced concern over the pH of medication infusions,
caution is still needed in the infusion of vesicant or irritant
medications because they increase the risk of thrombosis
with peripheral administration.58
In comparison with short peripheral catheters <4 cm, longer
midline catheters, 6-20 cm, placed using ultrasound guidance
have greater success and longer dwell times.59-63 Placement
of these catheters in the veins of the upper arm (ie, basilic or
cephalic) allows for increased blood ﬂow, greater dilution of
medications, and reduced risk of phlebitis and inﬁltration.4
The blood ﬂow from the lower arm to the upper arm has a 5-
fold difference from 20-40 mL/min to 100-150 mL/min.4 Dilu-
tion of medications reduces the risk of phlebitis, speciﬁcally
with vancomycin and other highly concentrated solutions.
Where a catheter is placed has a major inﬂuence on the ultimate
risk of complications. Midline catheters are positioned in a
secure, stable location in the mid-upper arm with a terminal
tip positioned below the shoulder, short of the axillary vein.
This protected point of entry allows ﬂat positioning, facilitating
the use of manufactured securement devices that reduce2015complications. Positioning the catheter below the axillary fold
of the armdnot entering the chestdaids in the prevention of
thrombosis for midlines.64
Dwell time for midline catheters exceeds that of peripheral and
even PICCs. Average dwell time for a peripheral catheter is 44
hours, for a PICC is 283.2 hours, for a midline is 393.6 hours,
and midline maximum dwell up to 296 days based on available
evidence.4,6,8,40,52,65-68 Current Infusion Nurses Society stan-
dards indicate midline dwell for 1-4 weeks and manufacturer’s
guidance typically speciﬁes 29 days. The move to clinically indi-
cated dwell and removal based on complications or end of ther-
apy rather than a speciﬁed dwell time may allow these midline
devices to be used in a variety of clinical settings for longer pe-
riods of time.69 The CDC states, “Midline catheters were in place
a median of 7 days, but as long as 49 days.”2 Although the ﬁnd-
ings of this study suggest that midline catheters can be changed
only when there is a speciﬁc indication, there are no prospective,
randomized studies associated with midline catheter extended
dwell vs routine replacement.70 In Australian studies,2,71,72 ran-
domized trials have established clinically indicated removal
based on short peripheral catheters and although more studies
are needed, this ﬁnding may be cautiously applied to midline
catheters in the same peripheral group. The CDC established a
category II recommendation for replacement of midline catheters
only when there is a speciﬁc clinical indication.
Patient satisfaction is the ﬁnal measure for device use. As
was reported by the hospitals in this study, implementation
of a midline program increased patient satisfaction and
improved the overall patient experience while establishing
the potential for each hospital to receive the Medicare bonus
payment under the “value-based purchasing” hospital compar-
ison performance measures. Longer dwell times, lower infec-
tion rates, low thrombosis incidence, and low complication
rates all add up to economic savings, better quality indicators,
and greater patient satisfactiondall key components of the Pa-
tient Protection and Affordable Care Act of 2010 and Press
Ganey Scores for hospitals in the United States.4,35,52,73,74
Limitations of the study include the small sample size, lack
of demographic information, and narrow outcome reporting. A
2-hospital study is not representative of a standard program,
but is offered as a sample of an effective process for implemen-
tation of midline catheter insertion integration into a current
vascular access program.
Conclusions
We found 2 hospitals that effectively established midline
insertion processes within a hospital nursing team program
initially for PICCs. Midline catheters are a reasonable alterna-
tive to PICCs or short peripheral catheters as a means to
providing reliable vascular access for the majority of patients
with DIVA, preventing multiple venipunctures and invasive
central line insertions. The aim of this study was to evaluate
the bedside midline programs in 2 hospitals, review the infec-
tion outcomes, and describe the processes used in the facilities.
The results demonstrate the low infection rates of midline cath-
eters at these facilities, effectively reducing bloodstream infec-
tion rates at their institutions by reducing total PICCs andj Vol 20 No 3 j JAVA j 185
central line catheter-days. Establishing an effective midline
program is more than simply learning an insertion technique
for a new product. Although gaining success with catheter
placement is important, working within the entire landscape
of vascular access to select the best device, apply evidence-
based indications for central venous catheter insertions, and
develop a strategy for placement of peripheral short and
midline catheters are also keys to creating a high quality pro-
gram that results in the best outcomes with highest patient and
nursing satisfaction. Creating a process for device selection
with standing orders or a protocol for midlines facilitates speed
to placement. Although more research is needed on the more
recently developed midline devices, evidence suggests midline
catheters provide a safe and reliable form of vascular access
that reduces costs and infections associated with central venous
catheters, especially those CVADs placed solely for patients
with difﬁcult venous access.
Based on our ﬁndings we offer the following process for
establishing a midline program.
1. Evaluate current CVAD use and CLABSI rates,
including economic inﬂuence on cost for insertion and
cost of infections.
2. Calculate potential cost avoidance with midline program.
3. Consider reimbursement or charges per unit for specialty
team placement with ultrasound guidance. Determine
cost of midlines and ultrasound-guided peripheral cath-
eter insertions and potential savings.
4. Gain champions among physicians, administration, and
infection prevention specialists. Establish buy-in for
the midline program.
5. Consider midline products, because 1 device may not ﬁt
all needs. A trial may include 2 similar devices or a third
with a different design.
6. Create a proposal and develop protocol for orders and
policies and procedures.
7. Gain approval for implementation of the protocol
through administration and medical staff review.
8. Create a plan for education and implement team training,
then expand throughout the hospital. Provide education
on risks/beneﬁts of various devices, indications, contra-
indications, maintenance, and aseptic technique for ac-
cess. Create patient education materials.
9. Locate clinicians with excellent venous access insertion
skills, preferably with ultrasound. Educate inserters; pro-
vide instruction on indications, care, and maintenance
for bedside staff; teach indications and use of midlines
to medical staff. Apply an algorithm or decision tree
for patients with difﬁcult access.75
10. Develop a Likert-type scale for device evaluation, then
begin a midline device trial.
11. Use a Likert-type scale to evaluate clinician feedback on
every insertion. Maintain documentation of any prob-
lems identiﬁed during daily rounding and assessment.
12. Deﬁne a strategy and individuals responsible for collec-
tion of statistics on success and outcomes with inserters
and devices. Keep statistics on number of devices
placed, attempts per device, vessel selected, arm, dwell186 j JAVA j Vol 20 No 3 j 20time, complications/infections, and special patient-
related considerations, such as dialysis.
13. Modify policies and procedures as needed.
14. Work toward gaining success knowing that the process
of gaining skills with AST improves over time, similar
to MST and ultrasound use (3-8 months).
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